Pulmonx Corporation (LUNG) CEO Glendon French on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/03/21
Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021GlobeNewsWire • 02/16/21
Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company GrowthGlobeNewsWire • 12/08/20
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPDGlobeNewsWire • 11/30/20
Pulmonx Announces Additional 16 Million Covered Lives for The Zephyr® Valve, a Minimally Invasive Treatment Option for Severe Emphysema (COPD)GlobeNewsWire • 11/02/20
Pulmonx Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesGlobeNewsWire • 10/05/20